Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling

Cell Death and Differentiation

Volumn 19, Issue 1, 2012, Pages 170-179

  Kawamura, S ^a   Sato, I ^b   Wada, T ^b   Yamaguchi, K ^b   Li, Y ^c   Li, D ^c   Zhao, X ^c   Ueno, S ^b   Aoki, H ^a   Tochigi, T ^a   Kuwahara, M ^a   Kitamura, T ^d   Takahashi, K ^b,e   Moriya, S ^b,e   Miyagi, T ^b,e  

^a Miyagi Cancer Center   (Japan)

^b MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c JILIN UNIVERSITY   (China)

^d THE UNIVERSITY OF TOKYO   (Japan)

^e TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

androgen receptor; EGR 1; prostate cancer; PSA; sialidase

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; EARLY GROWTH RESPONSE FACTOR 1; GANGLIOSIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEU3 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BCL 2; PROTEIN KINASE B; SIALIDASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL GROWTH; GENE SILENCING; HUMAN; HUMAN CELL; HYDROLYSIS; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

ANDROGENS; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE PROGRESSION; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; GENE SILENCING; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEURAMINIDASE; PHOSPHORYLATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 84856707555     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.83     Document Type: Article

References (37)

1. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004; 25: 276-308. (Pubitemid 38501396)
2. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10: 33-39. (Pubitemid 38524696)
3. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332: 1393-1398.
4. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001; 61: 3550-3555. (Pubitemid 32694958)
5. Edwards J, Krishna NS, Grigor KM, Bartlett JM. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer 2003; 89: 552-556. (Pubitemid 37026442)
6. Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 2003; 63: 1981-1989. (Pubitemid 36460867)
7. Rahman M, Miyamoto H, Chang C. Androgen receptor coregulators in prostate cancer: mechanism and clinical implications. Clin Cancer Res 2004; 10: 2208-2219. (Pubitemid 38445676)
8. Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, Svaren J et al. Impaired prostate tumorigenesis in Egr1-defficient mice. Nat Med 2001; 7: 101-107. (Pubitemid 32095648)
9. Yang S-Z, Eltoum IA, Abdulkadir SA. Enhanced EGR-1 activity promotes the growth of prostate cancer cells in an androgen-deleted environment. J Cell Biochem 2006; 97: 1292-1299.
10. Yang S-Z, Abdulkadir SA. Early growth response gene1 modulates androgen receptor signaling in prostate carcinoma cells. J Biol Chem 2003; 278: 39906-39911. (Pubitemid 37248554)
11. Miyagi T, Wada T, Yamaguchi K. Review: roles of plasma membrane-associated sialidase NEU3 in human cancers. Biochim Biophys Acta 2008; 1780: 532-537. (Pubitemid 351395305)
12. Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K. JB minireview: plasma membraneassociated sialidase as a crucial regulator of transmembrane signalling. J Biochem 2008; 144: 279-285.
13. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 2002; 99: 10718-10723.
14. Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, Arai Y et al. Plasma membraneassociated sialidase is up-regulated in renal cell carcinoma and promotes the interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 2006; 281: 7756-7764. (Pubitemid 43847389)
15. Nomura H, Tamada Y, Miyagi T, Suzuki A, Taira M, Suzuki N et al. Exression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the overy: its relationship with T factor of pTNM classification. Oncol Res 2006; 16: 289-297. (Pubitemid 46568076)
16. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acd Sci USA 2002; 99: 10231-10233.
17. Varki NM, Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 2007; 87: 851-857. (Pubitemid 47267816)
18. Lau KS, Dennis JW. N-glycans in cancer progression. Glycobiology 2008; 18: 750-760.
19. Miyagi T. Aberrant expression of sialidase and cancer progression. Proc Jpn Acad, Ser B Phys Biol Sci 2008; 84: 407-418.
20. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S et al. A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 2007; 26: 2483-2490. (Pubitemid 46597274)
21. Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K et al. Plasma membraneassociated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin-and fibronectin-derived signaling. Biochem J 2006; 394: 647-656.
22. Ravindranath MH, Muthugounder S, Presser N, Ye X, Brosman S, Morton DL. Endogenous immune response to gangliosides in patients with confined prostate cancer. Int J Cancer 2005; 116: 368-377. (Pubitemid 40993332)
23. Manin M, Baron S, Goossens K, Beaudoin C, Jean C, Veyssiere G et al. Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumor epithelial cells. Biochem J 2002; 366: 729-736.
24. Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999; 5: 280-285. (Pubitemid 29124362)
25. Gregory CW, Fei X, Ponguta LA, He B, Bill HM, French FS et al. Epidermel growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J Biol Chem 2004; 279: 7119-7130. (Pubitemid 38248859)
26. Berger R, Lin DI, Nieto M, Sicinska E, Garraway LA, Adams H et al. Androgen-dependent regulation of Her-2/neu in prostate cancer cells. Cancer Res 2006; 66: 5723-5728. (Pubitemid 43927125)
27. Pignon J-C, Koopmansch B, Nolens G, Delacroix L, Waltregny D, Winkler R. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Res 2009; 69: 2941-2949.
28. Cai C, Portnoy DC, Wang H, Jiang X, Chen S, Balk SP. Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2. Cancer Res 2009; 69: 5202-5209.
29. Yamaguchi K, Koseki K, Shiozaki M, Shimada Y, Wada T, Miyagi T. Regulation of plasma membrane-associated sialidase NEU3 gene by Sp1/Sp3 transcription factors. Biochem J 2010; 430: 107-117.
30. Ochiya T, Takahama Y, Nagahara S, Sumita Y, Hisada A, Itoh H et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med 1999; 5: 707-710. (Pubitemid 29289437)
31. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 2005; 102: 12177-12182. (Pubitemid 41291148)
32. Wierstra I. Sp1: emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun 2008; 372: 1-13.
33. Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer 2005; 41: 2438-2448. (Pubitemid 41540621)
34. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003; 31: 1007-1014. (Pubitemid 37329742)
35. Li K. Determination of sialic acids in human serum by reversed-phase liquid chromatography with fluorimatric detection. J Chromatogr 1992; 579: 209-213.
36. Burfeind P, Chernicky CL, Rininsland F, Ilan J, Ilan J. Antisense RNA to the type I insulinlike growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc Natl Acad Sci USA 1996; 93: 7263-7268. (Pubitemid 26243537)
37. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T et al. A close association of ganglioside-specific sialidase, Neu3, with caveolin in membrane microdomains. J Biol Chem 2002; 277: 26252-26259. (Pubitemid 34967114)